Alexander Rudensky, PhD
Alexander Rudensky is chairman of the immunology program and director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center (MSKCC), an investigator with the Howard Hughes Medical Institute, a Tri-Institutional Professor at MSKCC, the Rockefeller University and Cornell University, and professor at Gerstner School of Graduate Studies and Weill-Cornell Medical School. Prior to his joining MSKCC, he was professor of immunology at the University of Washington School of Medicine, Seattle. Dr. Rudensky received his doctorate degree from the Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow and postdoctoral training at Yale University Medical School with the late Dr. Charles A. Janeway, Jr. Dr. Rudensky is a world leader in studying the development and function of regulatory T cells, which play a crucial role in suppressing tumor immunity and autoimmunity.
Dr. Rudensky is an elected Member of the National Academy of Sciences, and National Academy of Medicine, and a Fellow of the American Academy of Arts and Sciences. He has been named a Thomson-Reuters Citation Laureate. He has received the Searle Scholar Award, the American Association of Immunologists-Pharmingen Investigator Award and the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology. He has been a member of numerous advisory and editorial boards including Cancer Research Institute, Damon Cancer Research Foundation, Cell and Immunity. He serves also as an Editor of the Journal of Experimental Medicine. Dr. Rudensky has authored over 190 publications.